Stocks
AbbVie (ABBV) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 42.6% | 41.6% | 31.6% | 26.5% | 28.8% | 26.9% | ||
| Changes by years, y/y, % | +16pp | -1pp | -10pp | -5pp | +2pp | +1.4% | |||
AbbVie. EBITDA margin, %
AbbVie. EBITDA margin, changes, pp
AbbVie (ABBV) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 33.0% | 28.2% | 22.3% | 32.3% | 24.6% | 26.9% | |
| Changes by years, y/y, % | -3pp | -6pp | -11pp | +29pp | -8pp | |||
| Changes by quarters, q/q, % | +29pp | -5pp | -6pp | +10pp | -8pp | |||
